Web Date: January 3, 2018
A banner year for new drugs
Last year was a high-water mark for drug approvals, with the U.S. Food & Drug Administration green-lighting 46 new molecular entities. By mid-June, FDA had given its nod to as many new molecules as were approved in all of 2016.
The 2017 number surpassed the nearly 20-year peak reached in 2015, when drug companies pushed through 45 new products.
Cancer treatments represented just over a quarter of all new molecules approved last year, though many . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society